Agios (AGIO) downgraded to Hold as Novo Nordisk rivalry and FDA/REMS risks hit sickle cell & thalassemia; pipeline and cash ...
Chemokines, acting as "traffic controllers" in the tumor microenvironment, regulate immune cell infiltration and local ...
Artiva Biotherapeutics (NASDAQ:ARTV) is prioritizing rheumatoid arthritis (RA) as the lead indication for its non-genetically ...
A self-proclaimed points nerd admits to losing $1200 annually through one basic supermarket loyalty program blunder. ... Read ...
ReAlta Life Sciences Closes Oversubscribed $40 Million Financing Round to Advance Pegtarazimod Phase 2 Program in Hypoxic ...
ADAG stock outlook: single-asset bet on ADG126 masked anti-CTLA-4 cancer therapy, with AACR 2026 catalysts, partnerships, and ...
Sr. Associate AD of Media Relations Doug Tammaro: We discuss his early days starring on the basketball courts of western ...
DPY30 acts as an epigenetic regulator to help pancreatic tumors maintain genomic stability Targeting DPY30 triggers immune cell infiltration and sensitizes tumors to immunotherapy DPY30 expression cou ...
Some animals can regrow lost body parts. Salamanders and frog tadpoles can rebuild entire limbs after amputation. Mammals ...
VANCOUVER, BC / ACCESS Newswire / April 14, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery sys ...
To most North American consumers, the concept of Quick Service Restaurants (QSR) within the foodservice segment signifies ...